Dagmar Scheel-Toellner

Colleges, School and Institutes

Research interests

My team uses a range of methods of both molecular and cellular immunology to explore the roles of immune cell populations in samples taken directly from sites of inflammation.
The overarching aim of our work is to identify novel clinical targets for the improved therapy of chronic inflammatory disease.
We recently identified a novel FcRL4+ B cell population in the rheumatoid joint and in other inflammatory diseases. Our findings suggest a pro-inflammatory and destructive role for this cell type, it is  specifically involved in the local autoimmune response. Investigation of their origin, differentiation, role in inflammatory diseases and potential as a clinical target is now an important focus of our work.


After qualifying as a pharmacist, I studied for a PhD in Immunology and Pharmaceutical Biology with Professor Johannes Gerdes at the University of Kiel  (awarded summa cum laude). I then joined the Department of Rheumatology at the University of Birmingham as a Research Fellow.

In 2004 I was awarded a 5 year Career Development Fellowship, followed by a Career Progression Fellowship by Arthritis Research UK leading to a tenured post as a Senior Research Fellow. In 2015 I was promoted to Reader.


Registered Pharmacist, University of Kiel, Germany

Dr rer. nat. (PhD in Immunology and Pharmaceutical Biology)

Member of the Higher Education Academy



Willingness to take PhD students


PhD projects

Dr Scheel-Toellner is currently supervising several doctoral researchers working on basic disease mechanisms in rheumatoid arthritis and other chronic inflammatory diseases. New team members are always welcome.